Identifying early signs of Alzheimer's disease and resilience factors
Novel Neurocognitive Markers of Risk for and Resilience to Cognitive Decline in Preclinical Alzheimer's Disease
This study is looking at new ways to spot early signs of Alzheimer's disease in older adults by examining brain activity, so we can help those at risk or who are doing well despite the challenges of aging.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10861735 on NIH RePORTER |
What this research studies
This research investigates how to detect Alzheimer's disease (AD) in its earliest stages and identify individuals who may be at risk or show resilience to cognitive decline. The approach involves using advanced techniques like electroencephalography (EEG) to study brain activity in older adults. By analyzing brain network dynamics and understanding the functional neuroanatomy related to AD, the research aims to uncover novel predictors of cognitive decline. The project also includes training for the researcher to develop expertise in clinical research design and statistical analysis.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who may be at risk for Alzheimer's disease or are experiencing early cognitive changes.
Not a fit: Patients with advanced Alzheimer's disease or significant cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of Alzheimer's disease and better strategies for prevention and intervention.
How similar studies have performed: Previous research has shown promise in using EEG and neuroanatomical assessments to predict cognitive decline, indicating that this approach may yield valuable insights.
Where this research is happening
Providence, United States
- Rhode Island Hospital — Providence, United States (Active)
Researchers
- Principal investigator: Korthauer, Laura — Rhode Island Hospital
- Study coordinator: Korthauer, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.